Sample Preparation in Global Metabolomics of Biological Fluids and Tissues - Proteomic and Metabolomic Approaches to Biomarker Discovery - page 72

55. Beltran A, Suarez M, Rodríguez MA, Vinaixa M,
Samino S, Arola L, et al. Assessment of compatibility
between extraction methods for NMR- and LC/
MS-based metabolomics. Anal Chem 2012; 84 (14):
5838 e 44.
56. Bruce SJ, Jonsson P, Antti H, Cloarec O, Trygg J,
Marklund SL, et al. Evaluation of a protocol

hydride-based stationary phase. J Sep Sci 2009;

32 (13):2200 e 8.
66. Courant F, Pinel G, Bichon E, Monteau F, Antignac JP,
Le Bizec B. Development of a metabolomic approach
based on liquid chromatography-high resolution mass
spectrometry to screen for clenbuterol abuse in calves.
Analyst 2009; 134 (8):1637 e 46.
67. Khin TM, Uehara T, Aoshima K, Oda Y. Polar anionic
metabolome analysis by nano-LC/MS with a metal
chelating agent. Anal Chem 2009; 81 (18):7766 e 72.
68. Darghouth D, Koehl B, Madalinski G, Heilier J,
Bovee P, Xu Y, et al. Pathophysiology of sickle cell
disease is mirrored by the red blood cell metabolome.
Blood 2011; 117 (6):e57 e 66.
69. Tiziani S, Emwas AH, Lodi A, Ludwig C, Bunce CM,
Viant MR, et al. Optimized metabolite extraction from
blood serum for 1H nuclear magnetic resonance
spectroscopy. Anal Biochem 2008; 377 (1):16 e 23.
70. Vuckovic D, Pawliszyn J. Systematic evaluation of
solid-phase microextraction coatings for untargeted
metabolomic pro

for

ling studies on human blood plasma
by combined ultra-performance liquid chromatog-
raphy/mass spectrometry: from extraction to data
analysis. Anal Biochem 2008; 372 (2):237 e 49.
57. Begley P, Francis-McIntyre S, DunnWB, Broadhurst DI,
Halsall A, Tseng A, et al. Development and perfor-
mance of a gas chromatography-time-of-

metabolic pro

ight mass
spectrometry analysis for large-scale nontargeted
metabolomic studies of human serum. Anal Chem 2009;
81 (16):7038 e 46.
58. Shellie RA, Welthagen W, Zrostlikova J, Spranger J,
Ristow M, Fiehn O, et al. Statistical methods for
comparing comprehensive two-dimensional gas

ight mass spectrometry
results: metabolomic analysis of mouse tissue extracts.
J Chromatogr A 2005; 1086 (1 e 2):83 e 90.
59. Denkert C, Budczies

chromatography-time-of- fluids by liquid

chromatography-mass spectrometry. Anal Chem 2011;
83 (6):1944 e 54.
71. Van QN, Veenstra TD, Issaq HJ. Metabolic pro

ling of biological

J, Kind T, Weichert W, ling

for the detection of bladder cancer. Curr Urol Rep 2011;
12 (1):34 e 40.
72. Rezzi S, Vera FA, Martin F-J, Wang S, Lawler D,
Kochhar S. Automated SPE-RP-HPLC fractionation of
bio

Tablack P, Sehouli J, et al. Mass spectrometry-

ling reveals different metab-
olite patterns in invasive ovarian carcinomas and
ovarian borderline tumors. Cancer Res 2006; 66 (22):
10795 e 804.
60. Hong Z, Lin Z, Liu Y, Tan G, Lou Z, Zhu Z, et al.
Innovative microwave-assisted oximation and silyla-
tion procedures for metabolomic analysis of plasma
samples using gas chromatography-mass spectrom-
etry. J Chromatogr A 2012; 1254 :14 e 22.
61. Lawton KA, Berger A, Mitchell M, Milgram KE,
Evans AM, Guo L, et al. Analysis of the adult human
plasma metabolome. Pharmacogenomics

based metabolic pro

uids combined to off-line NMR spectroscopy for
biomarker identi cation in metabonomics. J Chroma-

togr B: Anal Tech Biomed Life Sci 2008; 871 (2):271 e 8.
73. Idborg-Bjorkman H, Edlund P, Kvalheim OM,
Schuppe-Koistinen I, Jacobsson SP. Screening of
biomarkers in rat urine using LC/electrospray
ionization-MS and two-way data analysis. Anal Chem
2003; 75 (18):4784 e 92.
74. Lee SH, Woo HM, Jung BH, Lee J, Kwon OS, Pyo HS,
et al. Metabolomic approach to evaluate the toxico-
logical effects of nonylphenol with rat urine. Anal
Chem 2007; 79 (16):6102 e 10.
75. Giavalisco P, Hummel J, Lisec J, Inostroza AC,
Catchpole G, Willmitzer L. High-resolution direct
infusion-based mass spectrometry in combination
with whole 13C metabolome isotope labeling allows
unambiguous assignment of chemical sum formulas.
Anal Chem 2008; 80 (24):9417 e 25.
76. Evans AM, DeHaven CD, Barrett T, Mitchell M,
Milgram E. Integrated, nontargeted ultrahigh perfor-
mance liquid chromatography/electrospray ioniza-
tion tandem mass spectrometry platform for the
identi

2008; 9 (4):

383 e 97.
62. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP,
Cao Q, Yu J, et al. Metabolomic pro les delineate

potential role for sarcosine in prostate cancer

progression. Nature 2009; 457 (7231):910 e 4.
63. Czech C, Berndt P, Busch K, Schmitz O, Wiemer J,
Most V, et al. Metabolite pro ling of Alzheimer ' s

fluid. PLoS ONE 2012; 7 (2).
64. Whiley L, Godzien J, Ruperez FJ, Legido-Quigley C,
Barbas C. In-vial dual extraction for direct LC-MS
analysis of plasma for comprehensive and highly
reproducible metabolic

disease cerebrospinal

fingerprinting. Anal Chem

2012; 84 (14):5992 e 9.
65. Pesek JJ, Matyska MT, Loo JA, Fischer SM,
Sana TR. Analysis of hydrophilic metabolites in
physiological

cation of the small-
molecule complement of biological systems. Anal
Chem 2009; 81 (16):6656 e 67.

cation and relative quanti

fluids by HPLC-MS using a silica